-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$30.3337.8% Upside
Tyra Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Tyra Biosciences, Inc.?
Tyra Biosciences, Inc. has been rated by research analysts at Oppenheimer, Raymond James, H.C. Wainwright in the past 90 days.